Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

115
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

67
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Transfection of Exogenous Fibroblast Growth Factor (FGF) on Human Embryonic Stem Cells (ESCs) as a Regenerative Agent for Patients with Type 1 Diabetes Mellitus (T1DM)

Pages

  11-14

Abstract

 Type 1 Diabetes Mellitus (T1DM) is an autoimmune disorder which results in the INS pancreatic β-cell destruction and contributes to around 5 to 10% of all diabetes mellitus cases, especially in children. At the moment, the only treatment for T1DM is by insulin injection, which is injected in order to prevent the complication of T1DM. However, several studies have shown that combination between Embryonic Stem Cells (ESCs) and the Fibroblast Growth Factor 2 (FGF-2) may be a successful modality to treat T1DM. Actually, the ESCs may become the potential therapy in treating T1DM.

Cites

  • No record.

    • References

    Cite

    APA: Copy

    Nolan, John, Wijaya, Audrey Rachel, Lianto, Agatha Nadya, & Saraswati, Made Ratna. (2020). Transfection of Exogenous Fibroblast Growth Factor (FGF) on Human Embryonic Stem Cells (ESCs) as a Regenerative Agent for Patients with Type 1 Diabetes Mellitus (T1DM). INTERNATIONAL JOURNAL OF MEDICAL REVIEWS, 7(1), 11-14. SID. https://sid.ir/paper/754077/en

    Vancouver: Copy

    Nolan John, Wijaya Audrey Rachel, Lianto Agatha Nadya, Saraswati Made Ratna. Transfection of Exogenous Fibroblast Growth Factor (FGF) on Human Embryonic Stem Cells (ESCs) as a Regenerative Agent for Patients with Type 1 Diabetes Mellitus (T1DM). INTERNATIONAL JOURNAL OF MEDICAL REVIEWS[Internet]. 2020;7(1):11-14. Available from: https://sid.ir/paper/754077/en

    IEEE: Copy

    John Nolan, Audrey Rachel Wijaya, Agatha Nadya Lianto, and Made Ratna Saraswati, “Transfection of Exogenous Fibroblast Growth Factor (FGF) on Human Embryonic Stem Cells (ESCs) as a Regenerative Agent for Patients with Type 1 Diabetes Mellitus (T1DM),” INTERNATIONAL JOURNAL OF MEDICAL REVIEWS, vol. 7, no. 1, pp. 11–14, 2020, [Online]. Available: https://sid.ir/paper/754077/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top